Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INO-1001 in high-risk patients undergoing cardiopulmonary bypass cardiac surgery
2005-000464-95Phase 2Terminated
- Sponsor
- Inotek Pharmaceuticals
- Start
- Aug 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in complications of surgical procedures comparing INO-1001 intravenous with Placebo intravenous (2 arms). Primary endpoints: Primary efficacy endpoint and Safety and tolerability. Started Aug 2005; status: terminated.
02
Drugs
INO-1001
03
Conditions
complications of surgical procedures
Beyond the preview
Go deeper on 2005-000464-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000464-95.